11 completed, 5 recruiting, 2 unknown, 1 terminated. 19 Phase 2, 4 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Completed 11, Recruiting 5, Unknown 2, Terminated 1 |
| Phase 3 | 4 | Completed 3, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Pantoprazole: new trials by email Literature Review of Pantoprazole trials Research Report on Pantoprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial) Protonix (Pantoprazole) 40 mg q 12 hrs for 3 days, Pepcid (Famotidine) 20 mg q 12 hrs for 3 days - Acute Kidney Injury | Phase 2 | Recruiting | The University of Texas Health Science Center, Houston | 400 | 2025-01-24 | 2025-05-14 |
| PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease Omeprazole 40 mg IV, pantoprazole 40 mg iv - Morbidity | Phase 2 | Recruiting | Universidad Autonoma de Nuevo Leon | 120 | 2024-10-20 | 2026-11-18 |
| Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients Protonix (Pantoprazole) 40 mg q 12 hrs for 2 days, Protonix (pantoprazole) 40 mg q 24 hrs for 2 days - Acute Kidney Injury | Phase 2 / Phase 3 | Recruiting | The University of Texas Health Science Center, Houston | 100 | 2024-09-07 | 2026-02-19 |
| A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease BMS-986470, Placebo, Famotidine - Anemia, Sickle Cell, Healthy Volunteers | Phase 1 / Phase 2 | Recruiting | Bristol-Myers Squibb | 224 | 2024-07-17 | 2026-08-18 |
| Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor Pantoprazole, Famotidine - Acute Kidney Injury | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 100 | 2024-01-10 | 2026-03-10 |
| Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery pantoprazole, Placebo - Postoperative Nausea and Vomiting | Phase 2 | Recruiting | United States Naval Medical Center, Portsmouth | 132 | 2022-08-26 | 2025-05-21 |
| Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy Placebo, Pantoprazole - Pancreatic Cancer, Pancreas Cancer | Phase 2 | Terminated | Washington University School of Medicine | 56 | 2022-04-21 | 2025-05-06 |
| Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney Function pantoprazole - Proton Pump Inhibitor Allergy | Phase 2 | Unknown | Assiut University | 200 | 2019-12-01 | 2019-07-17 |
| Effect of Proton Pump Inhibitor of Daily Use for One Month on Kidney Function Test Pantoprazole 40mg - Proton Pump Inhibitor Allergy | Phase 2 | Unknown | Assiut University | 200 | 2019-11-01 | 2019-07-17 |
| Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy Pantoprazole 40mg, Placebo - Oncology, Breast Cancer | Phase 2 | Completed | University of Auckland, New Zealand | 160 | 2019-06-10 | 2022-05-25 |
| Aspirin in Young Psychotic Patients Aspirin, Placebo, Pantoprazole - Psychosis, Acute Psychosis | Phase 2 / Phase 3 | Completed | Clinic for Psychiatric Disorders, Dr Laza Lazarevic | 60 | 2017-07-20 | 2024-09-23 |
| Histamine Glutamate Antagonism in Stroke Diphenhydramine, Pantoprazole, Famotidine - Acute Cerebrovascular Accident, Cerebral Edema | Phase 2 | Completed | University of Florida | 3 | 2014-12-01 | 2015-12-15 |
| Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy Pantoprazole, High-dose methotrexate infusion duration - Osteosarcoma, Nephrotoxicity | Phase 2 | Completed | Children's Hospital of Philadelphia | 13 | 2013-04-01 | 2020-03-16 |
| Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer Pantoprazole - Prostate Cancer | Phase 2 | Completed | University Health Network, Toronto | 21 | 2013-01-01 | 2021-03-23 |
| Pantoprazole on Insulin Secretion in Diabetes Pantoprazole, placebo - Type 2 Diabetes | Phase 2 / Phase 3 | Completed | Coordinación de Investigación en Salud, Mexico | 14 | 2012-01-01 | 2014-02-21 |
| Incretin Effect and Use After Clinical Islet Transplantation Pantoprazole, Sitagliptin - Type 1 Diabetes | Phase 2 | Completed | University of Alberta | 8 | 2008-10-01 | 2015-06-18 |
| Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD. Pantoprazole, placebo - Gastroesophageal Reflux Disease | Phase 2 / Phase 3 | Completed | Southern Arizona VA Health Care System | 40 | 2008-04-01 | 2010-08-19 |
| Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage Pantoprazole - Peptic Ulcer Hemorrhage | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 12 | 2000-11-01 | 2013-02-08 |
| The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid Pantoprazole, Omeprazole - Gastrinoma, Zollinger Ellison Syndrome | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1983-02-03 | 2017-07-02 |
Acute Kidney Injury (3) · Neoplasms (2) · Anemia, Sickle Cell (1) · Brain Edema (1) · Breast Neoplasms (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Duodenal Neoplasms (1) · Esophagitis (1) · Gastrinoma (1) · Gastroesophageal Reflux (1) · Heartburn (1) · Hemorrhage (1) · Insulin Resistance (1)
The University of Texas Health Science Center, Houston (3) · Assiut University (2) · Bristol-Myers Squibb (1) · Children's Hospital of Philadelphia (1) · Clinic for Psychiatric Disorders, Dr Laza Lazarevic (1) · Coordinación de Investigación en Salud, Mexico (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Southern Arizona VA Health Care System (1) · United States Naval Medical Center, Portsmouth (1) · Universidad Autonoma de Nuevo Leon (1) · University Health Network, Toronto (1) · University of Alberta (1) · University of Auckland, New Zealand (1) · University of Florida (1) · Washington University School of Medicine (1)
United States (11) · Canada (3) · Mexico (2) · France (1) · Italy (1) · New Zealand (1) · Serbia (1) · United Kingdom (1)
Yafen Liang, MD (3) · Casey Timmerman, DO (1) · Frank M Balis, MD (1) · Manuel Gonzalez, PhD (1) · Natasha Leigh-Matijakovich, M.D. (1) · Navin Wewala, MBChB FRACP (1) · Peter Senior, MD, PhD (1) · Ricard Isaacs, MBChB FRACP (1) · Ronnie Fass, MD (1) · Vishnumurthy S Hedna, MD (1)
PMID 25704601, PMID 27087519, PMID 29445029, PMID 33677616, PMID 40394328
2023 (1)